Sentinel Surveillance for Congenital Rubella Syndrome - India 2016-2017.

Wednesday, 19th of September 2018 Print

 

MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1012-1016. doi: 10.15585/mmwr.mm6736a4.

Sentinel Surveillance for Congenital Rubella Syndrome - India 2016-2017.

Murhekar M Bavdekar A Benakappa A Santhanam S Singh K Verma S Sapkal GN Gupta N Verghese VP Viswanathan R Abraham AM Choudhary S Deshpande GN George S Goyal G Gupta PC Jhamb I John D Philip S Kadam S Sachdeva RK Kumar P Lepcha A Mahantesh S Manasa S Nehra U Munjal SK Nag VL Naik S Raj N Ram J Ratho RK Raut CG Rohit MK Sabarinathan R Shah S Singh P Singh MP Tiwari A Vaid N.

Abstract

Rubella infection during pregnancy can result in miscarriage fetal death stillbirth or a constellation of congenital malformations known as congenital rubella syndrome (CRS). The 11 countries in the World Health Organization (WHO) South-East Asia Region are committed to the elimination of measles and control of rubella and CRS by 2020. Until 2016 when the Government of Indias Ministry of Health and Family Welfare and the Indian Council of Medical Research initiated surveillance for CRS in five sentinel sites India did not conduct systematic surveillance for CRS. During the first 8 months of surveillance 207 patients with suspected CRS were identified. Based on clinical details and serologic investigations 72 (34.8%) cases were classified as laboratory-confirmed CRS four (1.9%) as congenital rubella infection 11 (5.3%) as clinically compatible cases and 120 (58.0%) were excluded as non-cases. The experience gained during the first phase of surveillance will be useful in expanding the surveillance network and data from the surveillance network will be used to help monitor progress toward control of rubella and CRS in India.

PMID: 30212443 DOI: 10.15585/mmwr.mm6736a4

 

Special Postings

;

Highly Accessed

Website Views

2041929